CLASS II Device recall · Reported 28 Oct 2020 · FDA Enforcement Report

Synapse PACS recalled by Fujifilm Medical Systems U.S.A

Fujifilm Medical Systems U.S.A is recalling Synapse PACS, distributed nationwide in the US. The recall was initiated on 11 Sep 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSynapse Software Version 5.6.1
Quantity recalled1

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0282-2021
FDA event ID
86494
Recalling firm
Fujifilm Medical Systems U.S.A, Lexington, MA
Classification
Class II
Status
Terminated
Recall initiated
11 Sep 2020
FDA classified
22 Oct 2020
Reported
28 Oct 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

11 Sep 2020Recall initiated by company
22 Oct 2020Classified by FDA+41 days
28 Oct 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not affected.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Synapse PACS Software Version 5.6.1 - Product Usage: intended for use as a web based application on an off-the shelf PC which meets or exceeds minimum specifications and is networked with a FUJIFILM Synapse PACS server.

Where it was distributed

US Nationwide distribution including in the state of Minnesota.

Nationwide Minnesota

Questions about this recall

Is Synapse PACS recalled?

Yes. Fujifilm Medical Systems U.S.A recalled Synapse PACS on 11 Sep 2020. The recall is Class II and its status is Terminated. Recall number Z-0282-2021.

Why was it recalled?

FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not affected.

Which lots are affected?

Synapse Software Version 5.6.1

Where was it sold?

US Nationwide distribution including in the state of Minnesota.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fujifilm Medical Systems U.S.A

All 37

Other Medical Software recalls

All 903